Dr. Melissa Frey explains the difference between Progeny and the CARE Program in providing patient history, analyzing criteria, and offering genetic testing in an OB-GYN…

Dr. Melissa Frey applies breast cancer risk models from Progeny and discovers a significant number were also at elevated risk for breast cancer.

Melissa Frey—a gynecologic oncologist, cancer geneticist, and researcher—discusses the critical importance of early cancer risk assessment and Ambry’s Progeny program.

For Rare Disease Day, genetic counselor Liam Riddle explores genetic testing solutions.

Genetic counselor Lauren Constantin discusses the importance of family health history and the benefit of Progeny to support genetic testing and run various cancer risk…